NCT06963281
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06963281
Title Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic - Arizona RECRUITING Pheonix Arizona 85054 United States Details
Mayo Clinic - Florida RECRUITING Jacksonville Florida 32224 United States Details
Mayo Clinic - Rochester RECRUITING Rochester Minnesota 55905 United States Details
Montefiore Cancer Center RECRUITING New York New York 10461 United States Details
NEXT Houston RECRUITING Houston Texas 77054 United States Details
NEXT Dallas RECRUITING Irving Texas 75039 United States Details
The sixth affiliated hospital, Sun Yat-sen University RECRUITING Guangzhou Guangdong China Details
Shandong Cancer Hospital RECRUITING Jinan Shandong China Details
Shanxi Cancer Hospital RECRUITING Taiyuan Shanxi China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field